NCT01463735View on ClinicalTrials.gov

Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Cirrhosis
Interventions
DIETARY_SUPPLEMENT

Vitamin E supplement (tocofersolan)

700 mg per day per os (i.e. 350 mg twice a day with meals)

Trial Locations (1)

1211

University Hospitals, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT01463735 - Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis | Biotech Hunter | Biotech Hunter